“…In 2008, safety, efficacy, usability, cost, and Food and Drug Administration (FDA) approval are required as five main necessities for use all over the world ( Spotnitz and Burks, 2008 , 2010 ), and other specific requirements like biodegradability, biocompatibility, mechanics, swelling ratio, stability, qualified water tightness, adjustable adhesion, and enhanced ability of healing process through the delivery of growth factors or active drugs are also be focused for actual usage. Accordingly, ideal hemostatic agents should simultaneously have abilities with rapid hemostasis, good biocompatibility, well-matched degradation, no adverse effects on wound healing and conducive to accelerating the healing process ( Howe and Cherpelis, 2013 ; Qin et al, 2015 ; Dowling et al, 2016 ; Momeni and Filiaggi, 2016 ). Furthermore, the important issues of quality, manufacturing cost, stability, swelling rate, safety and adjustable mechanics should also be considered and addressed ( Hsu et al, 2015 ).…”